Fetal Hydrops
4
1
1
1
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
5 treatments under study, led by Fetal Magnetocardiogram And Neonatal Electrocardiogram
Research Leaders
9 sponsors active, led by Shanghai First Maternity and Infant Hospital
Related Conditions
Often studied with 20 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
25.0%
1 terminated out of 4 trials
50.0%
-36.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia
In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)
Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment
Research Network
Common Treatments
- Fetal Magnetocardiogram And Neonatal Electrocardiogram1
- Substudy Only Maternalinfant Pharmacogenomic Assessment Postnatally1
- Intrauterine Intervention1
- In Utero Hematopoietic Stem Cell Transplantation1
- Prospective Observational Cohorts1
Active Sponsors
- Shanghai First Maternity and Infant Hospital1
- University of California, San Francisco1
- University of Wisconsin, Madison1
- California Institute for Regenerative Medicine (CIRM)1
- Advancing a Healthier Wisconsin Endowment1
Top Investigators
Medical College of Wisconsin
The Hospital for Sick Children, Toronto, ON, Canada
University of California, San Francisco
Related Conditions
- Brugada Syndrome1
- Fetal Tachycardia1
- Atrial Flutter1
- Pregnancy Loss1
- Tachycardia Supraventricular1